[go: up one dir, main page]

WO2004003010A3 - Recepteur hormonal nucleaire - Google Patents

Recepteur hormonal nucleaire Download PDF

Info

Publication number
WO2004003010A3
WO2004003010A3 PCT/GB2003/002807 GB0302807W WO2004003010A3 WO 2004003010 A3 WO2004003010 A3 WO 2004003010A3 GB 0302807 W GB0302807 W GB 0302807W WO 2004003010 A3 WO2004003010 A3 WO 2004003010A3
Authority
WO
WIPO (PCT)
Prior art keywords
binding domain
hormone receptor
ligano
nuclear hormone
containing protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2003/002807
Other languages
English (en)
Other versions
WO2004003010A2 (fr
Inventor
Christopher Benjamin Phelps
Richard Joseph Fagan
Janet Marjorie Allen
Kathryn Elizabeth Allen
Ilana Stancovski
Caroline Ann Hunt
Valerie Nathalie Pierron
Tom Phillips
Zinat Ellaheh Enayat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inpharmatica Ltd
Original Assignee
Inpharmatica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inpharmatica Ltd filed Critical Inpharmatica Ltd
Priority to AU2003242848A priority Critical patent/AU2003242848A1/en
Priority to EP03761712A priority patent/EP1530591A2/fr
Publication of WO2004003010A2 publication Critical patent/WO2004003010A2/fr
Publication of WO2004003010A3 publication Critical patent/WO2004003010A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne une protéine hCP41042.2 (ou LBDG7), identifiée comme contenant un nouveau domaine de liaison aux ligands d'un récepteur hormonal nucléaire. L'invention concerne également l'utilisation de cette protéine et d'une séquence d'acides nucléiques des gènes codant dans le diagnostic, la prévention et le traitement d'une maladie.
PCT/GB2003/002807 2002-07-01 2003-07-01 Recepteur hormonal nucleaire Ceased WO2004003010A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2003242848A AU2003242848A1 (en) 2002-07-01 2003-07-01 Nuclear hormone receptor ligano-binding domain containing protein
EP03761712A EP1530591A2 (fr) 2002-07-01 2003-07-01 Proteine contenant un domaine de liaison d'un recepteur d'hormone nucleaire

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0215228.8 2002-07-01
GB0215228A GB0215228D0 (en) 2002-07-01 2002-07-01 Protein

Publications (2)

Publication Number Publication Date
WO2004003010A2 WO2004003010A2 (fr) 2004-01-08
WO2004003010A3 true WO2004003010A3 (fr) 2004-02-26

Family

ID=9939657

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2003/002807 Ceased WO2004003010A2 (fr) 2002-07-01 2003-07-01 Recepteur hormonal nucleaire

Country Status (4)

Country Link
EP (1) EP1530591A2 (fr)
AU (1) AU2003242848A1 (fr)
GB (1) GB0215228D0 (fr)
WO (1) WO2004003010A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2558515C (fr) * 2004-03-05 2013-12-03 Sirs-Lab Gmbh Methode d'enrichissement et/ou de separation de l'adn procaryote au moyen d'une proteine pouvant former une liaison specifique avec de l'adn contenant des motifs cpg non-methyles

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BOURGUET W ET AL: "Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER TRENDS JOURNAL, CAMBRIDGE, GB, vol. 21, no. 10, October 2000 (2000-10-01), pages 381 - 388, XP002255271, ISSN: 0165-6147 *
FAGAN R ET AL: "BIOINFORMATICS, TARGET DISCOVERY ANDTHE PHARMACEUTICAL/BIOTECHNOLOGY INDUSTRY", CURRENT OPINION IN MOLECULAR THERAPEUTICS, CURRENT DRUGS, LONDON,, GB, vol. 2, no. 6, December 2000 (2000-12-01), pages 655 - 661, XP001007614, ISSN: 1464-8431 *
FUJINO TADAHIRO ET AL: "PCCX1, a novel DNA-binding protein with PHD finger and CXXC domain, is regulated by proteolysis", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 271, no. 2, 10 May 2000 (2000-05-10), pages 305 - 310, XP002262526, ISSN: 0006-291X *
JAN C ET AL: "Sequence annotation of nuclear receptor ligand-binding domains by automated homology modeling", PROTEIN ENGINEERING, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 13, no. 6, 2000, pages 391 - 394, XP002959343, ISSN: 0269-2139 *
LEE JEONG-HEON ET AL: "Identification and characterization of the DNA binding domain of CpG-binding protein", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, no. 48, 30 November 2001 (2001-11-30), pages 44669 - 44676, XP002262528, ISSN: 0021-9258 *
ROBINSON-RECHAVI M ET AL: "How many nuclear hormone receptors are there in the human genome?", TRENDS IN GENETICS, ELSEVIER, AMSTERDAM, NL, vol. 17, no. 10, 1 October 2001 (2001-10-01), pages 554 - 556, XP004328436, ISSN: 0168-9525 *
VOO KUI SHIN ET AL: "Cloning of a mammalian transcriptional activator that binds unmethylated CpG motifs and shares a CXXC domain with DNA methyltransferase, human trithorax, and methyl-CpG binding domain protein 1", MOLECULAR AND CELLULAR BIOLOGY, vol. 20, no. 6, March 2000 (2000-03-01), pages 2108 - 2121, XP002262527, ISSN: 0270-7306 *

Also Published As

Publication number Publication date
AU2003242848A8 (en) 2004-01-19
WO2004003010A2 (fr) 2004-01-08
EP1530591A2 (fr) 2005-05-18
GB0215228D0 (en) 2002-08-14
AU2003242848A1 (en) 2004-01-19

Similar Documents

Publication Publication Date Title
WO2003074073A3 (fr) Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications.
WO2004096856A3 (fr) Famille de proteines secretees
WO2006046072A3 (fr) Proteines renfermant vwfa et/ou le domaine ant_ig
WO2002070557A3 (fr) Domaine de liaison du ligand du recepteur hormonal nucleaire
WO2004003010A3 (fr) Recepteur hormonal nucleaire
WO2003000916A3 (fr) Proteines represseurs d'expression de la telomerase et leurs procedes d'utilisation
WO2006046073A3 (fr) Proteine du type c1q
WO2002070561A3 (fr) Domaine de liaison du ligand du recepteur hormonal nucleaire
WO2006043060A3 (fr) Proteine contenant le domaine mam
WO2004005346A8 (fr) Recepteur de l'hormone nucleaire
WO2001092468A3 (fr) Nouvelles compositions pour l'expression du transporteur 1 d'histidine de peptide humain et leurs procedes d'utilisation
WO2001014415A3 (fr) Gènes egfh2 et produits géniques
WO2004101618A3 (fr) Proteines associees au recepteur de progestine yol002c-cgi-45
WO2004009633A8 (fr) Recepteur de serotonine
WO2004003011A3 (fr) Recepteur hormonal nucleaire
WO2002083727A3 (fr) Sequences d'acides nucleiques relatives a des hyperplasies et tumeurs de la glande thyroide
WO2004056983A3 (fr) Proteines de metalloprotease
WO2004050703A8 (fr) Variant d'epissage de l'hormone de croissance hypophysaire humaine
WO2002033058A3 (fr) Proteases a cysteine
WO2005085285A3 (fr) Recepteurs hormonaux nucleaires
WO2004000882A3 (fr) Proteines
WO2002062845A3 (fr) Molecules d'adhesion
WO2002046380A3 (fr) Proteine kinase
WO2004026905A3 (fr) Proteines de transport/canal
WO2004011648A3 (fr) Cytochromes p450

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003761712

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003761712

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003761712

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP